Alkermes Plc Stock Performance
| ALKS Stock | USD 33.89 0.99 2.84% |
On a scale of 0 to 100, Alkermes Plc holds a performance score of 7. The firm shows a Beta (market volatility) of 1.04, which signifies a somewhat significant risk relative to the market. Alkermes Plc returns are very sensitive to returns on the market. As the market goes up or down, Alkermes Plc is expected to follow. Please check Alkermes Plc's potential upside, and the relationship between the total risk alpha and kurtosis , to make a quick decision on whether Alkermes Plc's price patterns will revert.
Risk-Adjusted Performance
Fair
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Alkermes Plc are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain forward-looking signals, Alkermes Plc unveiled solid returns over the last few months and may actually be approaching a breakup point. ...more
Actual Historical Performance (%)
One Day Return (2.84) | Five Day Return 1.53 | Year To Date Return 19.92 | Ten Year Return 3.48 | All Time Return 516.18 |
Last Split Factor 2:1 | Last Split Date 2000-05-15 |
1 | Alkermes lifts Avadel buyout offer after Lundbeck bid | 11/19/2025 |
2 | Should Alkermes Investors Reassess Prospects After Raised 2025 Guidance and Strong Q3 Results | 12/02/2025 |
3 | Disposition of 3748 shares by Hopkinson Craig C. of Alkermes Plc at 19.34 subject to Rule 16b-3 | 12/03/2025 |
4 | Acquisition by Wright Christopher I of 8013 shares of Alkermes Plc subject to Rule 16b-3 | 12/19/2025 |
5 | Voya Investment Management LLC Purchases 30,065 Shares of Alkermes plc ALKS | 12/23/2025 |
6 | Disposition of 5000 shares by Hopkinson Craig C. of Alkermes Plc at 19.34 subject to Rule 16b-3 | 01/08/2026 |
7 | Avadel Pharmaceuticals Announces that Avadel Shareholders Approve the Proposed Acquisition by Alkermes | 01/12/2026 |
8 | Is Alkermes Offering Value After Recent Biotech Sector Reaction To Its Portfolio | 01/15/2026 |
9 | FDA Grants Breakthrough Therapy Tag to LLYs Ovarian Cancer Candidate | 01/21/2026 |
10 | Jim Cramer on Alkermes I Think Its a Hold, Maybe a Weak One | 01/22/2026 |
11 | Corvus Pharmaceuticals Stock Rallies 209 percent in a Month Heres Why | 01/27/2026 |
12 | TEVAs Q4 Earnings Beat, Branded Drugs Drive Revenue Growth | 01/29/2026 |
| Begin Period Cash Flow | 457.5 M | |
| Total Cashflows From Investing Activities | -111.3 M |
Alkermes Plc Relative Risk vs. Return Landscape
If you would invest 3,017 in Alkermes Plc on November 3, 2025 and sell it today you would earn a total of 372.00 from holding Alkermes Plc or generate 12.33% return on investment over 90 days. Alkermes Plc is currently generating 0.2128% in daily expected returns and assumes 2.2547% risk (volatility on return distribution) over the 90 days horizon. In different words, 20% of stocks are less volatile than Alkermes, and 96% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Alkermes Plc Target Price Odds to finish over Current Price
The tendency of Alkermes Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 33.89 | 90 days | 33.89 | roughly 2.42 |
Based on a normal probability distribution, the odds of Alkermes Plc to move above the current price in 90 days from now is roughly 2.42 (This Alkermes Plc probability density function shows the probability of Alkermes Stock to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days the stock has the beta coefficient of 1.04 . This suggests Alkermes Plc market returns are related to returns on the market. As the market goes up or down, Alkermes Plc is expected to follow. Additionally Alkermes Plc has an alpha of 0.1785, implying that it can generate a 0.18 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Alkermes Plc Price Density |
| Price |
Predictive Modules for Alkermes Plc
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Alkermes Plc. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Alkermes Plc Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Alkermes Plc is not an exception. The market had few large corrections towards the Alkermes Plc's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Alkermes Plc, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Alkermes Plc within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.18 | |
β | Beta against Dow Jones | 1.04 | |
σ | Overall volatility | 1.93 | |
Ir | Information ratio | 0.08 |
Alkermes Plc Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Alkermes Plc for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Alkermes Plc can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Alkermes Plc is unlikely to experience financial distress in the next 2 years | |
| Alkermes Plc has a strong financial position based on the latest SEC filings | |
| Over 99.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from finance.yahoo.com: TEVAs Q4 Earnings Beat, Branded Drugs Drive Revenue Growth |
Alkermes Plc Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Alkermes Stock often depends not only on the future outlook of the current and potential Alkermes Plc's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Alkermes Plc's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 169.2 M | |
| Cash And Short Term Investments | 751.7 M |
Alkermes Plc Fundamentals Growth
Alkermes Stock prices reflect investors' perceptions of the future prospects and financial health of Alkermes Plc, and Alkermes Plc fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Alkermes Stock performance.
| Return On Equity | 0.22 | ||||
| Return On Asset | 0.0999 | ||||
| Profit Margin | 0.22 % | ||||
| Operating Margin | 0.23 % | ||||
| Current Valuation | 4.72 B | ||||
| Shares Outstanding | 165.12 M | ||||
| Price To Earning | (38.45) X | ||||
| Price To Book | 3.32 X | ||||
| Price To Sales | 3.68 X | ||||
| Revenue | 1.56 B | ||||
| Gross Profit | 1.31 B | ||||
| EBITDA | 494.86 M | ||||
| Net Income | 367.07 M | ||||
| Cash And Equivalents | 580.97 M | ||||
| Cash Per Share | 3.54 X | ||||
| Total Debt | 75.54 M | ||||
| Debt To Equity | 0.38 % | ||||
| Current Ratio | 2.38 X | ||||
| Book Value Per Share | 10.50 X | ||||
| Cash Flow From Operations | 439.12 M | ||||
| Earnings Per Share | 1.95 X | ||||
| Market Capitalization | 5.6 B | ||||
| Total Asset | 2.06 B | ||||
| Retained Earnings | (976.46 M) | ||||
| Working Capital | 950.16 M | ||||
| Current Asset | 754.96 M | ||||
| Current Liabilities | 236.21 M | ||||
About Alkermes Plc Performance
Assessing Alkermes Plc's fundamental ratios provides investors with valuable insights into Alkermes Plc's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Alkermes Plc is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 244.89 | 132.44 | |
| Return On Tangible Assets | 0.17 | 0.18 | |
| Return On Capital Employed | 0.24 | 0.25 | |
| Return On Assets | 0.16 | 0.17 | |
| Return On Equity | 0.23 | 0.24 |
Things to note about Alkermes Plc performance evaluation
Checking the ongoing alerts about Alkermes Plc for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Alkermes Plc help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Alkermes Plc is unlikely to experience financial distress in the next 2 years | |
| Alkermes Plc has a strong financial position based on the latest SEC filings | |
| Over 99.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from finance.yahoo.com: TEVAs Q4 Earnings Beat, Branded Drugs Drive Revenue Growth |
- Analyzing Alkermes Plc's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Alkermes Plc's stock is overvalued or undervalued compared to its peers.
- Examining Alkermes Plc's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Alkermes Plc's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Alkermes Plc's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Alkermes Plc's stock. These opinions can provide insight into Alkermes Plc's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Alkermes Stock Analysis
When running Alkermes Plc's price analysis, check to measure Alkermes Plc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Alkermes Plc is operating at the current time. Most of Alkermes Plc's value examination focuses on studying past and present price action to predict the probability of Alkermes Plc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Alkermes Plc's price. Additionally, you may evaluate how the addition of Alkermes Plc to your portfolios can decrease your overall portfolio volatility.